by The global optical genome mapping market is estimated to witness significant growth owing to technological advancements in genomic analysis applications. Optical genome mapping helps in detecting genome structural variations and pathogenic abnormalities across genomes. It involves direct imaging of DNA molecules stretched from single cells, which provides high-resolution genome maps. These genome maps help researchers gain comprehensive insights into genome structure, ploidy status, and other variation detection. The technology has wide applications in diagnosing genomic disorders, Cancer research, and synthetic biology research.
The Global Optical Genome Mapping Market is estimated to be valued at US$ 109.9 MN in 2024 and is expected to exhibit a CAGR of 2.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global optical genome mapping market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.
The key opportunities in the Optical Genome Mapping Market include developments in single-cell genome mapping technologies and integration of optical genome mapping with other omics technologies. Technological advancements such as machine learning-powered genome map analysis, high-throughput optical mapping, and nanopore sequencing integration are also expected to drive market growth.
Market drivers
Rising burden of genetic diseases and cancer globally is a key factor driving the demand for optical genome mapping technology. Early and accurate detection of genomic abnormalities using optical genome mapping aids in disease diagnosis and prognosis. Increasing applications of genome mapping in prenatal testing, agriculture, and drug discovery are also fueling the market growth. Growing R&D investments by key players to integrate novel technologies with optical genome mapping is further expected to boost the adoption of this technology over the forecast period.
Challenges in the Global Optical Genome Mapping Market
Early-stage companies developing optical genome mapping technologies face financial and technical challenges. Developing robust and accurate mapping platforms require extensive research and testing. Further, obtaining regulatory approvals for clinical use can be a long drawn process. Finding investors willing to fund disruptive but unproven technologies can be difficult. On the customer side, adoption of new genome mapping methods may be slow due to reluctance to change existing protocols and workflows. Convincing potential buyers about benefits over existing technologies requires extensive education and demonstration.
SWOT Analysis
Strength: Provides single molecule, high resolution views of genomes without biases of alignment and assembly. Weakness: Technically challenging process requiring specialized equipment and expertise. Opportunity: Potential applications in structural variation detection, genome assembly, disease research. Threats: Competition from established short read sequencing and long read technologies.
Geographical Regions
North America currently holds the largest share of the global optical genome mapping market attributed to presence of key players and availability of funding for genomics R&D. Growing genomics initiatives by government and private agencies are driving regional market growth.
Asia Pacific is poised to be the fastest growing regional market owing to increasing healthcare investments, rising importance given to precision medicine and large patient pool. China and India are emerging as lucrative markets with growing focus on genetics research and genome analysis capabilities.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research.
2. We have leveraged AI tools to mine information and compile it.
